Novartis Aktie
111,85
EUR
+1,70
EUR
+1,54
%
104,58
CHF
+0,56
CHF
+0,54
%
Werbung
Novartis Aktie Analyse
| 28.05.13 | Novartis halten | Deutsche Bank AG | |
| 03.05.13 | Novartis halten | Morgan Stanley | |
| 25.04.13 | Novartis halten | Morgan Stanley | |
| 24.04.13 | Novartis halten | S&P Equity Research | |
| 24.04.13 | Novartis halten | Independent Research GmbH | |
| 18.04.13 | Novartis halten | Deutsche Bank AG | |
| 15.04.13 | Novartis halten | Barclays Capital | |
| 28.01.13 | Novartis halten | Goldman Sachs Group Inc. | |
|
Werbung
|
|||
| 24.01.13 | Novartis Halten | Credit Suisse Group | |
| 16.01.13 | Novartis halten | Hamburger Sparkasse AG (Haspa) | |
| 10.01.13 | Novartis halten | Independent Research GmbH | |
| 13.12.12 | Novartis hold | Deutsche Bank AG | |
| 11.12.12 | Novartis halten | Norddeutsche Landesbank (Nord/LB) | |
| 10.12.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.11.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.11.12 | Novartis neutral | Citigroup Corp. | |
| 29.10.12 | Novartis halten | Independent Research GmbH | |
| 16.10.12 | Novartis neutral | Citigroup Corp. | |
| 08.10.12 | Novartis halten | Independent Research GmbH | |
| 12.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 07.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 06.09.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.09.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 31.08.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 29.08.12 | Novartis neutral | Citigroup Corp. | |
| 24.08.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 20.08.12 | Novartis neutral | Goldman Sachs Group Inc. | |
| 30.07.12 | Novartis hold | Vontobel Research | |
| 23.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis hold | Vontobel Research | |
| 20.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 19.07.12 | Novartis halten | Independent Research GmbH | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 19.07.12 | Novartis hold | Vontobel Research | |
| 18.07.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 12.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 12.07.12 | Novartis hold | Vontobel Research | |
| 12.07.12 | Novartis neutral | Citigroup Corp. | |
| 11.07.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 25.06.12 | Novartis neutral | UBS AG | |
| 19.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 19.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 05.06.12 | Novartis hold | Vontobel Research | |
| 04.06.12 | Novartis neutral | Exane-BNP Paribas SA | |
| 04.06.12 | Novartis neutral | Citigroup Corp. | |
| 04.06.12 | Novartis hold | Vontobel Research | |
| 29.05.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 23.05.12 | Novartis hold | Vontobel Research | |
Werbung
Werbung